{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:27:46Z","timestamp":1791217666961,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.pcad.2009.12.004","type":"journal-article","created":{"date-parts":[[2010,3,22]],"date-time":"2010-03-22T02:02:58Z","timestamp":1269223378000},"page":"401-409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"title":["Aldosterone: Role in the Cardiometabolic Syndrome and Resistant Hypertension"],"prefix":"10.1016","volume":"52","author":[{"given":"Adam","family":"Whaley-Connell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan S.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Sowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2009.12.004_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1559-4572.2008.00044.x","article-title":"The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus","volume":"4","author":"Ginsberg","year":"2009","journal-title":"J Cardiometab Syndr."},{"key":"10.1016\/j.pcad.2009.12.004_bib2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archinte.163.4.427","article-title":"The metabolic syndrome: prevalence and associated risk factor findings in the US Population from the Third National Health and Nutrition Examination Survey, 1988-1994","volume":"163","author":"Park","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pcad.2009.12.004_bib3","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1161\/01.CIR.0000140677.20606.0E","article-title":"Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults","volume":"110","author":"Malik","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2009.12.004_bib4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1524-6175.2005.04617.x","article-title":"Hypertension and the cardiometabolic syndrome","volume":"7","author":"Manrique","year":"2005","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"Supp 8A","key":"10.1016\/j.pcad.2009.12.004_bib5","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1016\/j.amjmed.2003.08.012","article-title":"Obesity as a cardiovascular risk factor","volume":"115","author":"Sowers","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.pcad.2009.12.004_bib6","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nature05487","article-title":"Mechanisms linking obesity with cardiovascular disease","volume":"444","author":"Van Gaal","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.pcad.2009.12.004_bib7","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.ki.5002006","article-title":"Metabolic risk factors and renal disease","volume":"71","author":"Sowers","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.pcad.2009.12.004_bib8","doi-asserted-by":"crossref","first-page":"H2009","DOI":"10.1152\/ajpheart.00522.2007","article-title":"Renin-aldosterone system and oxidative stress in cardiovascular insulin resistance","volume":"293","author":"Cooper","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pcad.2009.12.004_bib9","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.295.13.1549","article-title":"Prevalence of overweight and obesity in the United States,1999-2004","volume":"295","author":"Ogden","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2009.12.004_bib10","doi-asserted-by":"crossref","first-page":"R673","DOI":"10.1152\/ajpregu.00561.2007","article-title":"Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species","volume":"294","author":"Wei","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pcad.2009.12.004_bib11","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1152\/ajpendo.00258.2007","article-title":"Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2) rat","volume":"295","author":"Lastra","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.pcad.2009.12.004_bib12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1751-7176.2008.00012.x","article-title":"ASH position paper: treatment of hypertension in patients with diabetes\u2014an update","volume":"10","author":"Bakris","year":"2008","journal-title":"J Clin Hypertens (Greenwich)."},{"key":"10.1016\/j.pcad.2009.12.004_bib13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1159\/000088810","article-title":"Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy","volume":"25","author":"Hayden","year":"2005","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.pcad.2009.12.004_bib14","doi-asserted-by":"crossref","first-page":"776","DOI":"10.7326\/0003-4819-150-11-200906020-00005","article-title":"The emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension","volume":"150","author":"Sowers","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2009.12.004_bib15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000209744","article-title":"Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease","volume":"30","author":"Bomback","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.pcad.2009.12.004_bib16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/01.HYP.0000201443.63240.a7","article-title":"Effects of aldosterone on the vasculature","volume":"47","author":"Schiffrin","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2009.12.004_bib17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/HYPERTENSIONAHA.108.121954","article-title":"Mineralocorticoid receptor antagonism attenuates vascular apoptosis and injury via rescuing protein kinase B activation","volume":"53","author":"Wei","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2009.12.004_bib18","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/HYPERTENSIONAHA.107.093955","article-title":"Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells","volume":"50","author":"Hitomi","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2009.12.004_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.107.095489","article-title":"Aldosterone and vascular inflammation","volume":"51","author":"Brown","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2009.12.004_bib20","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archinte.168.11.1159","article-title":"Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion","volume":"168","author":"Gaddam","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pcad.2009.12.004_bib21","doi-asserted-by":"crossref","first-page":"F1013","DOI":"10.1152\/ajprenal.90646.2008","article-title":"Mineralcorticoid receptor antagonism attenuates kidney renin-angiotensin-aldosterone system mediated filtration barrier remodeling in the transgenic Ren2 rat","volume":"296","author":"Whaley-Connell","year":"2009","journal-title":"Am J of Physiol Renal Physiol"},{"key":"10.1016\/j.pcad.2009.12.004_bib22","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1681\/ASN.2006080944","article-title":"Enhanced aldosterone signaling in the early nephrology of rats with metabolic syndrome: possible contribution of fat-derived factors","volume":"17","author":"Nagase","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pcad.2009.12.004_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/01.HYP.0000231338.41548.fc","article-title":"Plasma aldosterone is independently associated with the metabolic syndrome","volume":"48","author":"Bochud","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2009.12.004_bib24","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and characteristics of the metabolic syndrome in primary aldosteronism","volume":"91","author":"Fallo","year":"2006","journal-title":"J Clin Endocrin Metab"},{"key":"10.1016\/j.pcad.2009.12.004_bib25","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.amjhyper.2007.03.012","article-title":"Adiponectin and insulin sensitivity in primary aldosteronism","volume":"20","author":"Fallo","year":"2007","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pcad.2009.12.004_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/HJH.0b013e3280108e6f","article-title":"Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study","volume":"25","author":"Giacchetti","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.pcad.2009.12.004_bib27","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/jc.2006-0736","article-title":"Insulin sensitivity in patients with primary aldosteronism: a follow-up study","volume":"91","author":"Catena","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pcad.2009.12.004_bib28","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1081\/ERC-200044122","article-title":"Fat cells may be the obesity-hypertension link: human adipogenic factors stimulate aldosterone secretion from adrenocortical cells","volume":"30","author":"Ehrhart-Bornstein","year":"2004","journal-title":"Endocr Res"},{"key":"10.1016\/j.pcad.2009.12.004_bib29","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1210\/endo.132.6.8504747","article-title":"Aldosterone stimulated differentiation of mouse 3T3-L1 cells into adipocytes","volume":"132","author":"Rondinone","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.pcad.2009.12.004_bib30","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1096\/fj.06-7970com","article-title":"Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis","volume":"21","author":"Caprio","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.pcad.2009.12.004_bib31","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","article-title":"Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines","volume":"117","author":"Guo","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2009.12.004_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1006871309864","article-title":"In vivo tissue specific modulation of rat insulin receptor gene expression in an experimental model of mineralocorticoid excess","volume":"185","author":"Campi\u00f3n","year":"1998","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.pcad.2009.12.004_bib33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/HJH.0b013e3282f4fcdb","article-title":"A possible association between primary aldosteronism and lower [beta]-cell function","volume":"26","author":"Mosso","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.pcad.2009.12.004_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1559-4572.2008.00006.x","article-title":"Pancreatic renin-angiotensin-aldosterone system in the cardiometabolic syndrome and type-2 diabetes","volume":"3","author":"Hayden","year":"2008","journal-title":"J Cardiometab Synd"},{"key":"10.1016\/j.pcad.2009.12.004_bib35","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2009.12.004_bib36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.jhh.1001554","article-title":"Prevalence of primary hyperaldosteronism in moderate to severe hypertension in Central Europe region","volume":"17","author":"Strauch","year":"2003","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.pcad.2009.12.004_bib37","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1097\/00004872-200411000-00026","article-title":"Low-renin status in therapy-resistant hypertension: a clue to efficient treatment","volume":"22","author":"Eide","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.pcad.2009.12.004_bib38","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.HYP.0000253258.36141.c7","article-title":"Association of adrenal steroids with hypertension and the metabolic syndrome in blacks","volume":"49","author":"Kidambi","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2009.12.004_bib39","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study","volume":"371","author":"Douma","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.pcad.2009.12.004_bib40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.jhh.1001554","article-title":"Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region","volume":"17","author":"Strauch","year":"2003","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.pcad.2009.12.004_bib41","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2009.12.004_bib42","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"117","author":"Calhoun","year":"2008","journal-title":"Circulation."},{"key":"10.1016\/j.pcad.2009.12.004_bib43","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/HYPERTENSIONAHA.108.123406","article-title":"Aldosterone and metabolic dysfunction: an unresolved issue","volume":"53","author":"Pimenta","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2009.12.004_bib44","doi-asserted-by":"crossref","first-page":"17A","DOI":"10.1016\/0002-9149(93)90240-D","article-title":"Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension","volume":"71","author":"Duprez","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2009.12.004_bib45","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/hrt.77.1.24","article-title":"Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass","volume":"77","author":"Schunkert","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.pcad.2009.12.004_bib46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons","volume":"351","author":"Vasan","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2009.12.004_bib47","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","article-title":"Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample","volume":"49","author":"Newton-Cheh","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2009.12.004_bib48","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2009.12.004_bib49","article-title":"Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants","author":"Ronconi","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2009.12.004_bib50","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1073\/pnas.96.5.2514","article-title":"Epithelial sodium channel regulated by aldosterone-induced protein sgk","volume":"96","author":"Chen","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pcad.2009.12.004_bib51","doi-asserted-by":"crossref","first-page":"F613","DOI":"10.1152\/ajprenal.2000.278.4.F613","article-title":"Regulation of sgk by aldosterone and its effects on the epithelial Na(+) channel","volume":"278","author":"Shigaev","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pcad.2009.12.004_bib52","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-induced inflammation in the rat heart : role of oxidative stress","volume":"161","author":"Sun","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pcad.2009.12.004_bib53","doi-asserted-by":"crossref","first-page":"H336","DOI":"10.1152\/ajpheart.01307.2005","article-title":"ANG II-induced cardiac molecular and cellular events: role of aldosterone","volume":"291","author":"Zhao","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pcad.2009.12.004_bib54","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1097\/01.hjh.0000194122.27475.6c","article-title":"Mechanisms for nongenomic and genomic effects of aldosterone on Na+\/H+ exchange in vascular smooth muscle cells","volume":"23","author":"Miyata","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.pcad.2009.12.004_bib55","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1046\/j.1523-1755.1999.00674.x","article-title":"Aldosterone activates Na+\/H+ exchange in vascular smooth muscle cells by nongenomic and genomic mechanisms","volume":"56","author":"Ebata","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.pcad.2009.12.004_bib56","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00041552-200403000-00007","article-title":"Brain mineralocorticoid receptors: orchestrators of hypertension and end-organ disease","volume":"13","author":"Gomez-Sanchez","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.pcad.2009.12.004_bib57","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1046\/j.1523-1755.2000.00972.x","article-title":"The amygdala: site of genomic and nongenomic arousal of aldosterone-induced sodium intake","volume":"57","author":"Sakai","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.pcad.2009.12.004_bib58","doi-asserted-by":"crossref","first-page":"R916","DOI":"10.1152\/ajpregu.00406.2002","article-title":"Cardiovascular and renal sympathetic activation by blood-borne TNF-alpha in rat: the role of central prostaglandins","volume":"284","author":"Zhang","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.pcad.2009.12.004_bib59","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1161\/HYPERTENSIONAHA.107.099796","article-title":"Does aldosterone upregulate the brain rennin-angiotensin system in rats with heart failure?","volume":"51","author":"Yu","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.pcad.2009.12.004_bib60","doi-asserted-by":"crossref","first-page":"E342","DOI":"10.1152\/ajpendo.00355.2004","article-title":"Is aldosterone synthesized within the rat brain?","volume":"288","author":"Gomez-Sanchez","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.pcad.2009.12.004_bib61","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.hco.0000231398.64362.94","article-title":"The central role of the brain in salt-sensitive hypertension","volume":"21","author":"Huang","year":"2006","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.pcad.2009.12.004_bib62","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.echo.2007.08.005","article-title":"Increased plasma aldosterone-to-renin ratio is associated with impaired left ventricular longitudinal functional reserve in patients with uncomplicated hypertension","volume":"21","author":"Choi","year":"2008","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.pcad.2009.12.004_bib63","doi-asserted-by":"crossref","DOI":"10.1007\/BF03346529","article-title":"Cardiac remodeling in patients with primary aldosteronism","author":"Galetta","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.pcad.2009.12.004_bib64","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jpeds.2009.02.029","article-title":"Blood aldosterone-to-renin ratio, ambulatory blood pressure, and left ventricular mass in children","volume":"155","author":"Li","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.pcad.2009.12.004_bib65","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/01.CIR.104.2.137","article-title":"Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes","volume":"104","author":"Harada","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2009.12.004_bib66","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1210\/en.2002-220120","article-title":"Selective aldosterone blockade prevents angiotensin II\/salt-induced vascular inflammation in the rat heart","volume":"143","author":"Rocha","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.pcad.2009.12.004_bib67","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1096\/fj.05-4642fje","article-title":"Aldosterone mediates angiotensin II\u2013induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase","volume":"20","author":"Johar","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.pcad.2009.12.004_bib68","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1210\/en.2006-1157","article-title":"Angiotensin II receptor type 1\u2013mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system","volume":"148","author":"Hirono","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.pcad.2009.12.004_bib69","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1210\/en.2006-1691","article-title":"Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling","volume":"148","author":"Stas","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.pcad.2009.12.004_bib70","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1291\/hypres.31.59","article-title":"Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker","volume":"31","author":"Furumatsu","year":"2008","journal-title":"Hypertens Res"},{"key":"10.1016\/j.pcad.2009.12.004_bib71","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.amjhyper.2004.06.029","article-title":"Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease","volume":"18","author":"Sato","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pcad.2009.12.004_bib72","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1291\/hypres.29.211","article-title":"Combination therapy with aldosterone blockade and renin-angiotensin inhibitors confers organ protection","volume":"29","author":"Sato","year":"2006","journal-title":"Hypertens Res"},{"key":"10.1016\/j.pcad.2009.12.004_bib73","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.amjmed.2006.03.038","article-title":"Aldosterone blockade: an emerging strategy for abrogating progressive renal disease","volume":"119","author":"Epstein","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.pcad.2009.12.004_bib74","first-page":"155","article-title":"Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure","volume":"51","author":"Bauersachs","year":"2003","journal-title":"Minerva Cardioangiol"},{"key":"10.1016\/j.pcad.2009.12.004_bib75","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.amjhyper.2007.05.008","article-title":"Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats","volume":"20","author":"Takeda","year":"2007","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.pcad.2009.12.004_bib76","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/HJH.0b013e32832810ed","article-title":"Aldosterone-receptor antagonism in hypertension","volume":"27","author":"Jansen","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.pcad.2009.12.004_bib77","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/j.ajkd.2008.02.297","article-title":"Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial","volume":"52","author":"Tylicki","year":"2008","journal-title":"Am J Kidney Dis"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062009001200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062009001200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:13:49Z","timestamp":1758500029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062009001200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0033062009001200"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2009.12.004","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aldosterone: Role in the Cardiometabolic Syndrome and Resistant Hypertension","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2009.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}